First Page | Document Content | |
---|---|---|
Date: 2014-07-10 11:19:17Pharmaceutical sciences Food and Drug Administration Clinical trial Food and Drugs Act Adverse effect Oxycodone Pharmacovigilance Patient safety Removal of cannabis from Schedule I of the Controlled Substances Act Medicine Health Pharmacology | Add to Reading ListSource URL: publications.gc.caDownload Document from Source WebsiteFile Size: 834,95 KBShare Document on Facebook |